MedPath

Biomarkers in Patients With Acute Myeloid Leukemia

Completed
Conditions
Leukemia
Registration Number
NCT01138319
Lead Sponsor
Children's Oncology Group
Brief Summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is studying biomarkers in patients with acute myeloid leukemia.

Detailed Description

OBJECTIVES:

* To determine whether clonally expanded somatic mitochondrial DNA mutations are associated with acute myeloid leukemia.

OUTLINE: Genomic DNA from blood samples obtained at diagnosis, remission, and relapse are analyzed for mitochondrial DNA mutations via PCR.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Association between clonally expanded somatic mitochondrial DNA mutations and acute myeloid leukemia
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath